| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Fetal misoprostol syndrome |
Causative agent (attribute) |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
2 |
| Misoprostol poisoning |
Causative agent (attribute) |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Accidental misoprostol poisoning |
Causative agent (attribute) |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| Intentional misoprostol poisoning |
Causative agent (attribute) |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| intoxication par le misoprostol d'intention indéterminée |
Causative agent (attribute) |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Misoprostol adverse reaction |
Causative agent (attribute) |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Allergy to misoprostol (finding) |
Causative agent (attribute) |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| Misoprostol overdose |
Causative agent (attribute) |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Accidental misoprostol overdose |
Causative agent (attribute) |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Intentional misoprostol overdose |
Causative agent (attribute) |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| surdose de misoprostol d'intention indéterminée |
Causative agent (attribute) |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| Naproxen 500mg tablet and misoprostol 200micrograms tablet pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| Product containing diclofenac sodium and misoprostol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| Product containing misoprostol and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
2 |
| Misoprostol 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| Diclofenac sodium + misoprostol 50mg/200mcg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| Diclofenac sodium + misoprostol 75mg/200mcg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| Product containing misoprostol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
|
| Accidental misoprostol poisoning |
Causative agent (attribute) |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Intentional misoprostol poisoning |
Causative agent (attribute) |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Allergy to misoprostol (finding) |
Causative agent (attribute) |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing misoprostol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing misoprostol in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Misoprostol 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Misoprostol 100 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
2 |
| Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Misoprostol (substance) |
Inferred relationship |
Some |
2 |
| Product containing diclofenac and misoprostol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Diclofenac- and misoprostol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Misoprostol 100 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Diclofenac and misoprostol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing only misoprostol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing only misoprostol and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
2 |
| Product containing only misoprostol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Misoprostol only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing only diclofenac and misoprostol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Fetal misoprostol syndrome |
Causative agent (attribute) |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely misoprostol 400 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely misoprostol 400 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely misoprostol 600 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely misoprostol 600 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Misoprostol 25 microgram vaginal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Misoprostol 25 microgram vaginal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Misoprostol 100 microgram vaginal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Misoprostol 100 microgram vaginal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely misoprostol 200 microgram/1 each conventional release vaginal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely misoprostol 200 microgram/1 each conventional release vaginal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Misoprostol (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]